{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:59:22Z","timestamp":1789095562248,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/s10156-012-0466-8","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T02:11:35Z","timestamp":1346724695000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia"],"prefix":"10.1016","volume":"19","author":[{"given":"Yasunori","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Masaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-012-0466-8_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/36.1.185","article-title":"Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients","volume":"36","author":"De Pauw","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-012-0466-8_bib0010","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","article-title":"Ceftazidime compared to piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer: a multicenter randomized trial","volume":"120","author":"Pauw","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6A","key":"10.1007\/s10156-012-0466-8_bib0015","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1016\/S0002-9343(96)00113-1","article-title":"Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenia patient","volume":"100","author":"Ramphal","year":"1996","journal-title":"Am J Med"},{"key":"10.1007\/s10156-012-0466-8_bib0020","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.40.5.1108","article-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer","volume":"40","author":"Cometta","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-012-0466-8_bib0025","series-title":"Febrile neutropenia","first-page":"63","article-title":"Cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients","author":"Breen","year":"1997"},{"key":"10.1007\/s10156-012-0466-8_bib0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","article-title":"1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever: Infectious Diseases Society of America","volume":"25","author":"Hughes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0466-8_bib0035","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1007\/s10156-012-0466-8_bib0040","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1086\/383054","article-title":"Evidence-based recommendations on antimicrobial use in febrile neutropenia in Japan","volume":"39","author":"Masaoka","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1007\/s10156-012-0466-8_bib0045","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/383046","article-title":"Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia. Japan Febrile Neutropenia Study Group","volume":"39","author":"Tamura","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0466-8_bib0050","series-title":"Febrile neutropenia","first-page":"53","article-title":"The changing spectrum of bacterial infections in febrile neutropenic patients","author":"Rolston","year":"1997"},{"key":"10.1007\/s10156-012-0466-8_bib0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajh.10236","article-title":"Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination on 4th-generation cephalosporin\u00a0+\u00a0aminoglycosides: comparative study","volume":"71","author":"Tamura","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1007\/s10156-012-0466-8_bib0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0924-8579(03)00002-5","article-title":"Use of imipenem as empirical treatment of febrile neutropenia","volume":"21","author":"Klastersky","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1007\/s10156-012-0466-8_bib0065","first-page":"382","article-title":"Clinical analysis of antibiotic treatment for febrile neutropenia","volume":"58","author":"Shibata","year":"2005","journal-title":"Jpn J Antibiot"},{"key":"10.1007\/s10156-012-0466-8_bib0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.bmt.1701520","article-title":"Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"23","author":"Salazar","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1007\/s10156-012-0466-8_bib0075","first-page":"687","article-title":"Therapeutic effects of meropenem against severe infections in patients with hematopoietic disorders: Hanshin Study Group of Hematopoietic Disorders and Infection","volume":"45","author":"Sugiyama","year":"1992","journal-title":"Jpn J Antibiot"},{"key":"10.1007\/s10156-012-0466-8_bib0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0959-8049(94)90412-X","article-title":"Factors associated with bacteremia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"30A","author":"Viscoli","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1007\/s10156-012-0466-8_bib0085","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/AAC.39.2.445","volume":"39","author":"Cometta","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-012-0466-8_bib0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01695660","article-title":"Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution","volume":"15","author":"Gonz\u00e1lez-Barca","year":"1996","journal-title":"Eur J Clin Microb Infect Dis"},{"key":"10.1007\/s10156-012-0466-8_bib0095","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-012-0466-8_bib0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJM200201243460402","article-title":"Persistent fever in patients with neutropenia","volume":"346","author":"Corey","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10156-012-0466-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:50:21Z","timestamp":1761159021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X13701879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1341321X13701879"],"URL":"https:\/\/doi.org\/10.1007\/s10156-012-0466-8","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-012-0466-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}